![Dr Janet Hammond](https://enterprisetherapeutics.com/wp-content/uploads/2024/06/Janet.png)
Dr Janet Hammond
Dr Janet Hammond has over 20 years’ experience in the pharmaceutical industry, during which time she has overseen the development and successful approval of several drugs. She is currently Chief Development Officer at Atea Pharmaceuticals, a Boston-based biotech focused on the development of antiviral drugs for life-threatening infectious diseases. Prior to joining Atea, Janet was Vice President and Head of Infectious Diseases and General Medicine at AbbVie, Inc., and Senior Vice President and Global Head of Infectious Diseases at Hoffmann-la Roche. She obtained her MD and PhD from the University of Cape Town where she specialised in Pulmonary/Critical Care Medicine, holds a Masters in Clinical Investigation from Johns Hopkins University, and carried out training in Infectious Diseases at Duke and Johns Hopkins Universities.